logo
Key agency sticks to its guns on peak oil demand

Key agency sticks to its guns on peak oil demand

Axios5 hours ago

The International Energy Agency is sticking by its controversial view that global oil demand growth will end this decade, even dipping slightly in 2030.
Why it matters: The timing of a peak — and more importantly, the slope of any decline — affects everything from emissions to investment strategies.
The latest: IEA sees growth of roughly 700,000 barrels per day this year and next, and then increases slow to "a trickle" for the rest of the decade.
"This is driven by below-trend economic growth, weighed down by global trade tensions and fiscal imbalances, and the accelerating substitution away from oil in the transport and power generation sectors."
The annual look-aheads are based on today's policies and market trends and needless to say are stuffed with uncertainties.
Zoom in: While IEA is sticking with its overall demand outlook, specific markets are shifting.
Chinese oil consumption in 2030 will only be "marginally higher" than in 2024, IEA now projects, citing rapid EV growth and other forces.
But in the U.S., IEA revised its 2030 demand forecast upward by 1.1 million barrels per day, citing lower gasoline prices and "loss of momentum in EV adoption."
The intrigue: The agency just lowered its U.S. shale outlook as low prices prompt companies to scale back and the sector consolidates.
It now sees shale largely plateauing for the rest of the 2020s.
The new report projects U.S. production of "light tight oil" (basically shale) at 9.8 mbd in 2030, compared to 10.6 mbd in 2030 in last year's version.
The bottom line: IEA predicts global production capacity rising faster than demand, with a "comfortably supplied oil market through 2030."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wall Street Can't Ignore This: China's Biotech Stocks Are Exploding--One Is Up 283%
Wall Street Can't Ignore This: China's Biotech Stocks Are Exploding--One Is Up 283%

Yahoo

time19 minutes ago

  • Yahoo

Wall Street Can't Ignore This: China's Biotech Stocks Are Exploding--One Is Up 283%

China's biotech sector is on a tear. The Hang Seng Biotech Index has climbed over 60% since Januaryhandily beating China tech's AI-fueled rallythanks to a wave of billion-dollar licensing deals and red-hot IPOs. Pfizer said last month it will pay up to $1.25 billion to license an experimental cancer drug from 3SBio (TRSBF) and invest another $100 million in the firm's stock. Just weeks later, Bristol-Myers Squibb inked a deal worth up to $11.5 billion for a cancer therapy originally licensed by Germany's BioNTech from China's Biotheus. Those two deals alone have ignited a frenzy. 3SBio shares have soared 283% year-to-date. RemeGen, another licensing contender, is up 270% as of June. Investors aren't just chasing dealsthey're also buying into the IPO pipeline. Duality Biotherapeutics, which focuses on cancer immunotherapies, more than doubled on its first day of trading in April and has since gained 189%. Jiangsu Hengrui, China's biggest drugmaker by market value, surged 25% on debut in May. Even more striking? The pace of dealmaking. M&A involving Chinese biotech firms hit $36.9 billion in Q1more than half of global totals. Chinese biotech is having its own DeepSeek moment, said Dong Chen, chief Asia strategist at Pictet Wealth Management, referencing the AI boom that fueled Chinese tech earlier this year. Still, not everyone's chasing the highs. Some healthcare-focused funds are rotating out, preferring stable compounders with steady dividends. Others see the recent mega-deals as one-offs, and aren't ready to assign premium multiples just yet. But even with macro headwinds, analysts like those at Jefferies remain optimistic. Many Chinese biotech firms already operate as partners to U.S. drugmakers, not exportersmeaning tariffs may have limited impact. And with top scientific talent returning home amid geopolitical tensions, R&D momentum could accelerate. In short: China's biotech surge might still be in the early innings. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

MP Materials (MP) Rallies 13.4% on Rare Earths Deal
MP Materials (MP) Rallies 13.4% on Rare Earths Deal

Yahoo

time24 minutes ago

  • Yahoo

MP Materials (MP) Rallies 13.4% on Rare Earths Deal

MP Materials Corp. (NYSE:MP) is one of the . MP Materials rose for a third day on Monday, jumping 13.42 percent to end at $34.65 apiece as investor sentiment was boosted by the United States and China's progress on rare earths mineral exports. Last week, the US and China engaged in a three-day trade negotiation in London that was said to have focused on rare earths negotiations. Under the agreement, China will loosen restrictions on rare earths, allowing companies to supply magnets and elements to US firms. MP Materials Corp. (NYSE:MP)—the only rare earth producer in the US, also benefitted from the trade talks progress given its heavy reliance on Chinese companies in the refinery of elements. Heavy machinery at work in a mining facility, excavating the earth for rare earth minerals. It can be learned that MP Materials Corp. (NYSE:MP) stopped shipping mines to China for processing after the Chinese government previously slapped a 125-percent tariff on US imports. While we acknowledge the potential of MP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nvidia Sounds Alarm: Export Curbs Could Backfire on U.S. Tech
Nvidia Sounds Alarm: Export Curbs Could Backfire on U.S. Tech

Yahoo

time26 minutes ago

  • Yahoo

Nvidia Sounds Alarm: Export Curbs Could Backfire on U.S. Tech

June 17 - Nvidia (NASDAQ:NVDA) CEO Jensen Huang cautioned that U.S. export restrictions may strengthen China's tech industry rather than preserve U.S. AI leadership. Huang said if the U.S. pulls back, companies like Huawei could fill the gap. Huawei will have China covered, he said, suggesting controls could accelerate China's self-sufficiency in semiconductors and AI. Warning! GuruFocus has detected 4 Warning Signs with NVDA. The warning comes amid trade tensions. Tariffs on Chinese imports reached elevated levels before easing to around 55% after recent agreements. These measures have drawn retaliation from Beijing and weigh on the U.S. economy. The World Bank now expects U.S. growth to slow to about 1.4% in 2025, and the OECD has trimmed its outlook for major economies as trade frictions persist. Consumers may face higher costs due to tariffs. Huang noted that export curbs could reduce Nvidia's revenue from China, limiting funding for research and development and potentially affecting its competitive edge over rivals. As U.S. policy seeks to balance national security with economic interests, his remarks highlight the unintended risk of accelerating competitors' capabilities while sidelining American firms in a key market. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store